ULBP4 activators belong to a distinctive chemical class that operates at the molecular level, influencing cellular interactions and immune responses. ULBP4, short for UL16-binding protein 4, is a transmembrane glycoprotein expressed in various tissues, primarily implicated in the regulation of immune surveillance. The class of ULBP4 activators comprises a diverse range of compounds that possess the ability to modulate the expression or function of ULBP4, thereby exerting an impact on immune recognition and response mechanisms.
Chemically, ULBP4 activators can be characterized by their ability to bind selectively to ULBP4, initiating a cascade of intracellular events. These compounds often interact with specific domains on the ULBP4 protein, triggering conformational changes or altering its post-translational modifications. The ultimate consequence of such interactions is the modulation of ULBP4's interaction with its cognate receptors, such as natural killer (NK) cells or other immune cells. Understanding the intricacies of ULBP4 activation and its chemical modulators provides valuable insights into the fundamental mechanisms governing immune responses and opens avenues for further research into the broader implications of manipulating this specific molecular pathway.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that turns on gene expression by modifying chromatin structure. It could potentially stimulate ULBP4 expression indirectly through these gene regulatory actions. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
An HSP90 inhibitor that triggers the cellular stress response. By inducing cellular stress, it could potentially stimulate ULBP4 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that causes an accumulation of damaged or misfolded proteins, triggering cellular stress. This stress could potentially stimulate ULBP4 expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
A chemotherapy drug that initiates DNA damage. The resulting cellular stress and DNA damage response could potentially stimulate ULBP4 expression. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
A reactive oxygen species that can initiate oxidative stress. This stress could potentially stimulate ULBP4 expression. | ||||||
2,4-Dinitrophenol, wetted | 51-28-5 | sc-238345 | 250 mg | $59.00 | 2 | |
A compound that disrupts normal cellular respiration, triggering cellular stress. This stress could potentially stimulate ULBP4 expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
A compound that inhibits N-linked glycosylation in the ER, instigating ER stress. The unfolded protein response triggered by this stress could potentially stimulate ULBP4 expression. | ||||||